Early research (Phase 1)Study completedNCT07051538
What this trial is testing
A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis
Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 64